• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • GPs

BVCA summit: fund financing boom necessitates tailoring

  • Katharine Hidalgo
  • Katharine Hidalgo
  • 13 October 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Speaking on a panel at the British Private Equity & Venture Capital Association (BVCA) summit, representatives from 17Capital, Wafra, Travers Smith and Permira discussed the positive and negative aspects of a rapidly growing fund financing tool box, and the need for tailoring those services to the needs of stakeholders.

The coronavirus crisis has encouraged an already growing interest in fund financing services, with major GPs turning to preferred equity and NAV-based finance facilities for emergency liquidity, Unquote reported in April.

Tom Rotherham-Winqvist, a managing director at Wafra, spoke of the growing trend on a panel at BVCA's recent online summit: "There's been general acceptance of the tool, and bigger players are making use of it. Anything that's going to create value and provide a reasonable price of leverage is generally going to be a good thing."

One notable example is 17Capital's £125m preferred equity facility for Exponent Private Equity Partners III, agreed in July 2020.

Rotherham-Winqvist continued: "You've got a real diversity of LPs with different interests, liquidity profiles and demands, and this is all wedged into a pretty homogenous fund structure. You need to solve that disconnect to achieve heterogeneity."

Roberto Biondi, global head of financing and partner at Permira, said the firm had been considering some of these facilities, but had decided against it: "Our LPs were pushing for co-investment opportunities. In addition, we've moved on to a faster fundraising cycle, so we always have the ability to raise. Finally, we feel we would need to have full disclosure and transparency with LPs, and that seems to be an additional burden for both sides of the table."

Rotherham-Winqvist also noted the extra burden for communication, negotiation and discussion with regard to these facilities: "It is a complex asset class and, depending on the LP, many don't have lots of human resources, so adding complexity is a challenge. It's a question of adding an additional layer that requires transparency, clarity and communication with LPs."

Katie McMenamin, a partner at Travers Smith, noted the importance of tailoring when it comes to choosing facilities: "It has become much more customary to think about how GPs use these tools. This will become more mainstream, and the ones that execute on these facilities will be situations where it fits with the story, both for the provider and the manager, where they're confident that this is the right way to solve the problem."

Permira's Biondi spoke about control over the assets involved: "The ability to choose the moment to exit companies is paramount in our work and fund financing has triggers that could force you to begin exiting assets. Our initial reaction was that that was something we wouldn't do."

Moderator Owen James, an investment director at 17Capital, said that premature exiting was not an issue with preferred equity, but mainly with NAV-based facilities, and that there was quite a lot of breathing space with these provisions.

McMenamin agreed: "It has been a massive sticking point, but contracts have been written to ameliorate these issues. NAV-based financing providers have offered stand-still periods, consultation periods and provisions mandating discussions on how to deal with breaches, before the security has been triggered."

While some market participants are concerned about the use of proceeds of a NAV-based facility, Wafra's Rotherham-Winqvist said he had yet to see a situation where the use of proceeds was not reasonable: "The challenge is, it is on a case-by-case basis, and you have to look carefully at each situation. If equity positions are being subordinated, that is something to be considered. You must ask if there is equal impact on the LP and GP, as well as the costs behind carry. Is there a further effect on the value of the IRR number? We're not against using these facilities, but LPs should have choice."

Inflating IRR numbers has been a hotly contested issue that expands beyond fund financing. Biondi said: "In the use of proceeds of NAV-based financing, the one we would consider the worst is to manage IRR, or even carry distribution. That would go against what we have done in our history. It is an interesting element of IRR losing its meaning, but LPs are now very happy to strip out all IRR-enhancing tactics. We think that's a good way to look at it for fundraising."

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • GPs
  • Financing
  • LPs
  • UK / Ireland
  • United Kingdom
  • Travers Smith
  • Permira
  • 17Capital
  • Fund financing

More on GPs

EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
Canary Wharf and the financial centre of London
IPO offers CVC chance to become multi-asset consolidator

Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl

  • GPs
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013